These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32511395)

  • 41. Effect of the povidone iodine, hypertonic alkaline solution and saline nasal lavage on nasopharyngeal viral load in COVID-19.
    Batioglu-Karaaltin A; Yigit O; Cakan D; Akgul O; Yigit E; Yilmaz YZ; Cakir KB; Ciftci G; Boyoğlu NS; Cagliyan A; Can E; Dikme O; Hacioglu Y; Balkan II; Enver O; Ozdogan HA
    Clin Otolaryngol; 2023 Jul; 48(4):623-629. PubMed ID: 36973223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disinfection methods against SARS-CoV-2: a systematic review.
    Viana Martins CP; Xavier CSF; Cobrado L
    J Hosp Infect; 2022 Jan; 119():84-117. PubMed ID: 34673114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of povidone-iodine composite on the elimination of bacterial biofilm.
    Jeronimo LP; Choi MR; Yeon SH; Park SK; Yoon YH; Choi SH; Kim HJ; Jang IT; Park JK; Rha KS; Kim YM
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):884-892. PubMed ID: 32479710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread.
    Bentley K; Stanton RJ
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between Virucidal Efficacy and Free Iodine Concentration of Povidone-Iodine in Buffer Solution.
    Wada H; Nojima Y; Ogawa S; Hayashi N; Sugiyama N; Kajiura T; Ueda T; Morimoto S; Yokota K
    Biocontrol Sci; 2016; 21(1):21-7. PubMed ID: 27009506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine.
    Wutzler P; Sauerbrei A; Klöcking R; Brögmann B; Reimer K
    Antiviral Res; 2002 May; 54(2):89-97. PubMed ID: 12062394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular iodine is not responsible for cytotoxicity in iodophors.
    Freeman C; Duan E; Kessler J
    J Hosp Infect; 2022 Apr; 122():194-202. PubMed ID: 35124143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-influenza Activity of Povidone-Iodine-Integrated Materials.
    Shoji M; Ichihashi K; Sriwilaijaroen N; Mayumi H; Morikane S; Takahashi E; Kido H; Suzuki Y; Takeda K; Kuzuhara T
    Biol Pharm Bull; 2023 Sep; 46(9):1231-1239. PubMed ID: 37357386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro studies evaluating the efficacy of mouth rinses on Sars-Cov-2: A systematic review.
    Tadakamadla J; Boccalari E; Rathore V; Dolci C; Tartaglia GM; Tadakamadla SK
    J Infect Public Health; 2021 Sep; 14(9):1179-1185. PubMed ID: 34399189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products.
    Ito H; Ito T; Hikida M; Yashiro J; Otsuka A; Kida H; Otsuki K
    Dermatology; 2006; 212 Suppl 1():115-8. PubMed ID: 16490988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiviral effect of mouthwashes against SARS-COV-2: A systematic review.
    Mezarina Mendoza JPI; Trelles Ubillús BP; Salcedo Bolívar GT; Castañeda Palacios RDP; Herrera Lopez PSG; Padilla Rodríguez DA; Uchima Koecklin KH
    Saudi Dent J; 2022 Mar; 34(3):167-193. PubMed ID: 35125835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective, randomized, open-label trial of early versus late povidone-iodine gargling in patients with COVID-19.
    Matsuyama A; Okura H; Hashimoto S; Tanaka T
    Sci Rep; 2022 Nov; 12(1):20449. PubMed ID: 36443363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework.
    Naqvi SHS; Citardi MJ; Cattano D; Ostrosky-Zeichner L; Knackstedt MI; Karni RJ
    J Otolaryngol Head Neck Surg; 2020 Oct; 49(1):77. PubMed ID: 33109269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
    Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
    J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents.
    Cegolon L; Javanbakht M; Mastrangelo G
    Int J Hyg Environ Health; 2020 Sep; 230():113605. PubMed ID: 32898838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virucidal efficacy of chlorhexidine: a systematic review.
    Fernandez MDS; Guedes MIF; Langa GPJ; Rösing CK; Cavagni J; Muniz FWMG
    Odontology; 2022 Apr; 110(2):376-392. PubMed ID: 34637092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined Nasal, Oropharyngeal Povidone Iodine Plus Glycyrrhizic Acid Sprays, Accelerate Clinical and Laboratory Recovery and Reduces Household Transmission of SARS-CoV-2: A Randomized Placebo-Controlled Clinical Trial.
    Elsersy HE; Zahran MAH; Elbakry AE; Abd-Elwahab M; Ahmed MM; Elgandy MS; Mohammed EHM; Elewa NM
    Front Med (Lausanne); 2022; 9():863917. PubMed ID: 35514746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
    Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
    J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.